Emerging evidence implicates FUNDC1 dysregulation in neurodegenerative diseases, particularly Alzheimer’s disease (AD), where defective mitophagy exacerbates hallmark pathologies including Aβ plaque deposition and hyperphosphorylated Tau-driven neurofibrillary tangles. Here, FUNDC1 is linked to Alzheimer disease.